Trial intelligence / Profile preview

Atomoxetine effects on EEG and driving in adults with ADHD

NL-OMON24935Recruiting

Sponsor
Utrecht University
Start
Sep 2009
Modality
Small Molecules
Countries
1
01

Overview

Trial of atomoxetine in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Utrecht University. Primary endpoints: Standard Deviation of Lateral Position, P3a in auditory oddball task and 2 more. Started Sep 2009; status: recruiting.

02

Drugs

atomoxetine
03

Conditions

attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on NL-OMON24935.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON24935.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call